Literature DB >> 19466515

Effects of chronic obstructive pulmonary disease on coronary atherosclerosis.

Ramazan Topsakal1, Nihat Kalay, Ibrahim Ozdogru, Yakup Cetinkaya, Sema Oymak, Mehmet Gungor Kaya, Ali Dogan, Mehmet Tugrul Inanc, Ali Ergin.   

Abstract

The chronic systemic inflammation and oxidative stress are important features in chronic obstructive pulmonary disease (COPD). Atherosclerosis is accepted as an inflammatory disease. Both local and systemic inflammation and oxidative stress negatively affect the atherosclerotic process. Metabolic alterations, systemic inflammation, and neurohormonal activation frequently occur in patients with COPD. However, the impact of COPD on intensity and severity of atherosclerosis and morphology of stenotic lesions in patients with established coronary artery disease by coronary angiography is unknown. Eighty-eight patients who were diagnosed with COPD disease were enrolled in the study. Eighty-two patients without any pulmonary disease were included in the control group. Coronary angiography and blood gases analysis were performed in all patients. Gensini score and Extent score were used to evaluate the intensity and severity of atherosclerosis. Lesion morphologies were defined in all patients. The mean number of affected coronary arteries was 2.5 +/- 0.6 in the COPD group and 2.1 +/- 0.7 in the control group (P = 0.004). The mean Extent score was 37 +/- 16 in the COPD group and 23 +/- 11 in the control group (P = 0.001). The Gensini score in the COPD group was significantly higher than that in the control group (respectively 10.9 +/- 6.3 vs 6.6 +/- 4.1, P = 0.01). The number of critical lesions, and type B and C lesions were higher in the COPD group. Multivariate analysis demonstrated that COPD was independently predictive for Gensini score (odds ratio 1.371; 95% confidence interval 1.682-9.228; P = 0.002) and Extent score (odds ratio 1.648; 95% confidence interval 2.023-13.339; P = 0.001). Severity and intensity of atherosclerosis increases in COPD and atherosclerotic lesions have worse morphological properties in COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19466515     DOI: 10.1007/s00380-008-1103-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans.

Authors:  D G Kiely; R I Cargill; B J Lipworth
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

Review 2.  Systemic effects of chronic obstructive pulmonary disease.

Authors:  A G N Agustí; A Noguera; J Sauleda; E Sala; J Pons; X Busquets
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

3.  Effect of acute hypercapnia on alpha atrial natriuretic peptide, renin, angiotensin II, aldosterone, and vasopressin plasma levels in patients with COPD.

Authors:  F Chabot; P M Mertes; N Delorme; F V Schrijen; C G Saunier; J M Polu
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

4.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

5.  Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.

Authors:  Geja J Hageman; Ingrid Larik; Herman Jan Pennings; Guido R M M Haenen; Emiel F M Wouters; Aalt Bast
Journal:  Free Radic Biol Med       Date:  2003-07-15       Impact factor: 7.376

6.  Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; P Howard
Journal:  Eur Respir J       Date:  1991-11       Impact factor: 16.671

7.  The effect of changes in arterial PCO2 on neuroendocrine function in man.

Authors:  R M Leach; M L Forsling
Journal:  Exp Physiol       Date:  2004-03-16       Impact factor: 2.969

8.  Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries.

Authors:  Kazunori Otsui; Nobutaka Inoue; Seiichi Kobayashi; Rio Shiraki; Tomoyuki Honjo; Motonori Takahashi; Ken-Ichi Hirata; Seinosuke Kawashima; Mitsuhiro Yokoyama
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

9.  A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors.

Authors:  D R Sullivan; T H Marwick; S B Freedman
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

10.  Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein.

Authors:  Seiichi Kobayashi; Nobutaka Inoue; Yoshitaka Ohashi; Mitsuyoshi Terashima; Kiyoko Matsui; Takao Mori; Hideki Fujita; Kojiro Awano; Katsuya Kobayashi; Hiroshi Azumi; Junya Ejiri; Ken-ichi Hirata; Seinosuke Kawashima; Yoshitake Hayashi; Hiroshi Yokozaki; Hiroshi Itoh; Mitsuhiro Yokoyama
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-12       Impact factor: 8.311

View more
  11 in total

1.  Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography.

Authors:  Jin-Jin Kim; Dong-Bin Kim; Sung-Won Jang; Eun Joo Cho; Kiyuk Chang; Sang Hong Baek; Ho-Joong Youn; Wook Sung Chung; Ki-Bae Seung; Tai-Ho Rho; Jung Im Jung; Byung-Hee Hwang
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-14       Impact factor: 2.357

2.  The relationship between pulmonary emphysema and kidney function in smokers.

Authors:  Divay Chandra; Jason A Stamm; Paul M Palevsky; Joseph K Leader; Carl R Fuhrman; Yingze Zhang; Jessica Bon; Steven R Duncan; Robert A Branch; Joel Weissfeld; David Gur; Mark T Gladwin; Frank C Sciurba
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

3.  Coronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary disease.

Authors:  Thomas Gaisl; Christian Schlatzer; Esther I Schwarz; Mathias Possner; Julia Stehli; Noriane A Sievi; Christian F Clarenbach; Damini Dey; Piotr J Slomka; Philipp A Kaufmann; Malcolm Kohler
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

4.  Comparison of cardiac rehabilitation outcomes in individuals with respiratory, cardiac or no comorbidities: A retrospective review.

Authors:  Mika L Nonoyama; Susan Marzolini R Kin; Dina Brooks; Paul Oh
Journal:  Can J Respir Ther       Date:  2016

5.  Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Ming Zhang; Yun-Jiu Cheng; Wei-Ping Zheng; Guang-Hui Liu; Huai-Sheng Chen; Yu Ning; Xin Zhao; Li-Xiao Su; Li-Juan Liu
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

6.  High prevalence of COPD in atherosclerosis patients.

Authors:  Izabela Tuleta; Tarik Farrag; Laura Busse; Carmen Pizarro; Christian Schaefer; Simon Pingel; Georg Nickenig; Dirk Skowasch; Nadjib Schahab
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-19

7.  Relationship between Pulmonary Function Tests and Severity of Coronary Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Arsalan Salari; Fardin Mirbolouk; Asiyeh Ashouri; Pedram Salari; Hanie Shadrou; Zahra Mehdipour; Mahboobeh Gholipour
Journal:  Tanaffos       Date:  2020-11

8.  Relation of Pulmonary Function Impairment and Coronary Artery Calcification by Multi-detector Computed Tomography in Group Exposed to Inorganic Dusts.

Authors:  Won-Jeong Lee; Jae Hoon Shin; So Young Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-02-28

9.  Evaluation of von Willebrand factor in COPD patients.

Authors:  Thiago Prudente Bártholo; Cláudia Henrique da Costa; Rogério Rufino
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

10.  Evaluation for airway obstruction in adult patients with stable ischemic heart disease.

Authors:  M Mahendra; Sunil Kumar S; Nagaraj Desai; Jayaraj Bs; Mahesh Pa
Journal:  Indian Heart J       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.